Evidence-Based Medicine Guidelines
Continued prescription of antidepressant drugs for relapse prevention in depression
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Continued Prescription of Antidepressant Drugs for Relapse Prevention in Depression." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/450611/all/Continued_prescription_of_antidepressant_drugs_for_relapse_prevention_in_depression.
Continued prescription of antidepressant drugs for relapse prevention in depression. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/450611/all/Continued_prescription_of_antidepressant_drugs_for_relapse_prevention_in_depression. Accessed September 26, 2023.
Continued prescription of antidepressant drugs for relapse prevention in depression. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/450611/all/Continued_prescription_of_antidepressant_drugs_for_relapse_prevention_in_depression
Continued Prescription of Antidepressant Drugs for Relapse Prevention in Depression [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2023 September 26]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/450611/all/Continued_prescription_of_antidepressant_drugs_for_relapse_prevention_in_depression.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Continued prescription of antidepressant drugs for relapse prevention in depression
ID - 450611
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/450611/all/Continued_prescription_of_antidepressant_drugs_for_relapse_prevention_in_depression
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
